CNS Neuroscience & Therapeutics

Papers
(The H4-Index of CNS Neuroscience & Therapeutics is 46. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Additional Cover193
Front cover178
Issue Information168
Supratentorial hydrocephalus with an anti‐glial fibrillary acidic protein (GFAP) antibody‐positive status: A case report133
Front Cover121
Disruptions in Cognitive‐Affective Circuitry in Major Depression Disorder: Insights From REST‐Meta‐MDD and Its Implication for Predicting TMS Treatment Efficacy120
Effects of Transcranial Direct Current Stimulation Targeting Dorsolateral Prefrontal Cortex and Orbitofrontal Cortex on Somatic Symptoms in Patients With Major Depressive Disorder: A Randomized, Doubl103
Therapeutic potential of human stem cell transplantations for Vanishing White Matter: A quest for the Goldilocks graft101
A rare case of encephalomyelitis caused by Candida parapsilosis98
Shared genetics and causal association between plasma levels of SARS‐CoV‐2 entry receptor ACE2 and Alzheimer's disease91
Recognizing Alzheimer's disease from perspective of oligodendrocytes: Phenomena or pathogenesis?87
Reactive astrocytes targeting with oral vitamin A: Efficient neuronal regeneration for Parkinson's disease treatment and reversal of associated liver fibrosis81
The role of the thalamus in modular functional networks in temporal lobe epilepsy with cognitive impairment79
Optic nerve compression associated with visual cortex functional alteration in dysthyroid optic neuropathy: A combined orbital and brain imaging study76
Da‐Bu‐Yin‐Wan and Qian‐Zheng‐San Alleviate Parkinson's Disease by Activating the Keap1/Nrf2/ HO ‐1 Pathway to Positively Regulate Oxidative Stress76
Effectiveness and mechanisms of combined use of antioxidant nutrients in protecting against oxidative stress‐induced neuronal loss and related neurological deficits75
Association of Plaque Characteristics With New Ischemic Lesions After Carotid Artery Stenting74
scRNA‐seq and proteomics reveal the distinction of M2‐like macrophages between primary and recurrent malignant glioma and its critical role in the recurrence73
Mendelian randomization study and meta‐analysis exploring the causality of age at menarche and the risk of intracerebral hemorrhage and ischemic stroke70
Why we should raise stroke awareness in the younger population?70
Effective Connectivity Predicts Surgical Outcomes in Temporal Lobe Epilepsy: A SEEG Study69
Thalamic Volumes and Functional Networks Linked With Self‐Regulation Dysfunction in Major Depressive Disorder68
Expert opinions from the 2024 closed door round table discussion on improving stroke prehospital care globally66
Gender‐specific prognosis models reveal differences in subarachnoid hemorrhage patients between sexes65
Elevated Activity in Left Homologous Music Circuits Is Inhibitory for Music Perception but Mediated by Structure–Function Coupling64
Decreased cold‐inducible RNA‐binding protein (CIRP) binding to GluRl on neuronal membranes mediates memory impairment resulting from prolonged hypobaric hypoxia exposu60
Alterations in metabolome and lipidome in patients with in‐stent restenosis58
Differences in survival prognosticators between children and adults with H3K27M‐mutant diffuse midline glioma57
The Neuroprotection of 1,2,4‐Triazole Derivative by Inhibiting Inflammation and Protecting BBB Integrity in Acute Ischemic Stroke56
First‐in‐Human Study of BAT4406F, an ADCC‐Enhanced Fully Humanized Anti‐CD20 Monoclonal Antibody in Patients With Neuromyelitis Optica Spectrum Disorders56
Rapamycin Reduces Amyloid‐β Plaques and Improves Behavioral Performance in a Sex‐Dependent Manner in Mouse Models of Amyloidosis55
The interaction between intestinal microenvironment and stroke54
A neuromarker for deficit syndrome in schizophrenia from a combination of structural and functional magnetic resonance imaging53
Differential inflammation responses determine the variable phenotypes of epilepsy induced by GABRG2 53
From Regeneration Failure to Functional Restoration: Unlocking the Neuronal‐Intrinsic Regenerative Capacity as a Therapeutic Frontier for Optic Neuropathy and Glaucoma53
Chidamide Is Screened to Suppress Epileptogenesis in Mice Models via Blocking Histone Deacetylase 153
Comments on “Jolkinolide B Mitigates Cerebral Ischemia–Reperfusion Injury by Promoting Microglial M1 / M2 52
Central Thalamic Deep Brain Stimulation Modulates Autonomic Nervous System Responsiveness in Disorders of Consciousness50
Role of Hippocampal Glutamatergic Synaptic Alterations in Sevoflurane‐Induced Cognitive Dysfunction in Aged Mice49
Combined behavioral and EEG evidence for the 70 Hz frequency selection of short‐term spinal cord stimulation in disorders of consciousness49
Therapeutic effects of exendin‐4 on spinal cord injury via restoring autophagy function and decreasing necroptosis in neuron49
Variants in BRWD3 associated with X‐linked partial epilepsy without intellectual disability49
Benefit of endovascular treatment for primary versus secondary medium vessel occlusion: A multi‐center experience48
Hypoxic postconditioning drives protective microglial responses and ameliorates white matter injury after ischemic stroke48
Examining the Impact of Microglia on Ischemic Stroke With an Emphasis on the Metabolism of Immune Cells47
Comparing the Risk of Epilepsy in Patients With Simple Congenital Heart Diseases: A Prospective Cohort Study46
1.9008660316467